Lys454

Site Information
KACSLLGkLRLECAD SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 50292020
Available spectra: 1 CST

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 3 , 4 , 5 , 6 )
Disease tissue studied:	lung cancer ( 1 , 2 , 3 , 4 , 5 , 6 ) , non-small cell lung cancer ( 2 , 5 , 6 ) , non-small cell lung adenocarcinoma ( 1 , 2 , 5 ) , non-small cell large cell lung carcinoma ( 5 ) , non-small cell squamous cell lung carcinoma ( 1 ) , small-cell lung cancer ( 3 , 4 )
Relevant cell line - cell type - tissue:	Calu-3 (pulmonary) ( 6 ) , DMS153 (pulmonary) ( 2 ) , DMS53 (pulmonary) ( 4 ) , DMS79 (pulmonary) ( 3 ) , HCC15 (pulmonary) ( 1 ) , HCC827 (pulmonary) ( 6 ) , LOU-NH91 (squamous) ( 1 ) , lung ( 1 , 2 , 3 , 4 , 5 , 6 ) , NCI-H128 (pulmonary) ( 3 ) , NCI-H1299 (pulmonary) ( 5 ) , NCI-H1417 (pulmonary) ( 3 ) , NCI-H1437 (pulmonary) ( 2 ) , NCI-H1650 (pulmonary) ( 6 ) , NCI-H1703 (squamous) ( 1 ) , NCI-H1734 (pulmonary) ( 5 ) , NCI-H1944 (pulmonary) ( 5 ) , NCI-H1975 (pulmonary) ( 6 ) , NCI-H2073 (pulmonary) ( 1 , 2 ) , NCI-H209 (pulmonary) ( 2 , 3 ) , NCI-H2106 (pulmonary) ( 6 ) , NCI-H2342 (pulmonary) ( 1 ) , NCI-H358 (pulmonary) ( 5 ) , NCI-H446 (pulmonary) ( 4 ) , NCI-H460 (pulmonary) ( 5 ) , NCI-H524 (pulmonary) ( 3 ) , NCI-H526 (pulmonary) ( 4 ) , NCI-H69 (pulmonary) ( 4 ) , NCI-H82 (pulmonary) ( 4 ) , NCI-H838 (pulmonary) ( 2 )

References
1	Rikova K (2013) CST Curation Set: 20218; Year: 2013; Biosample/Treatment: cell line, H2342, H2073, Lou-NH91, HCC15, H1703; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK Curated Info
2	Rikova K (2013) CST Curation Set: 20221; Year: 2013; Biosample/Treatment: cell line, H838, DMS153, H2073, H209, H1437; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK Curated Info
3	Rikova K (2013) CST Curation Set: 20213; Year: 2013; Biosample/Treatment: cell line, H1417, DMS79, H128, H209, H524; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK Curated Info
4	Rikova K (2013) CST Curation Set: 20214; Year: 2013; Biosample/Treatment: cell line, DMS53, H526, H69, H82, H446; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK Curated Info
5	Rikova K (2013) CST Curation Set: 20216; Year: 2013; Biosample/Treatment: cell line, H1299, H1944, H358, H1734, H460; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK Curated Info
6	Rikova K (2013) CST Curation Set: 20217; Year: 2013; Biosample/Treatment: cell line, H1650, HCC827, H1975, Calu-3, H2106; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK Curated Info